Pilecki Derek Steven purchased $83K of GROW (indirect holdings)

Pilecki Derek Steven purchased 33,034 indirectly-held shares of U S GLOBAL INVESTORS INC (GROW) at $2.50 on 2026-11-06.

Original reporting
SEC EDGAR · Pilecki Derek Steven
Published Nov 9, 2026, 7:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 7:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GROW
Neutral
high confidence
Mentioned
$GROW
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GROWNeutralLow
01

Why it matters

The modest size of the purchase suggests limited market impact, but it confirms insider confidence.

02

Market read

New insider purchase filing; low trading relevance.

03

What to watch

Insider's overall stake is already large; incremental buy may not reflect new information.

Relevance 4/10Novelty 3/10Timing: filing posted today, after market close

Background

SEC Form 4 filing discloses an insider's open‑market purchase of GROW shares.

Company-level read

Ticker impact

$GROWNeutralHigh confidence
Context

Form 4 shows insider Derek Pilecki bought 33,034 shares of GROW for $82,690, increasing his holdings to 1,162,333 shares.

Expected impact

slight upside as market prices in the insider buy

Evidence & confidence

The transaction size is modest relative to market cap, so impact is limited but positive.

Market effects

minimal effect on the financial services sector

none

none

Counterpoint

The purchase could be a routine portfolio rebalancing, not a signal of confidence.

Key entities

  • Derek Pilecki

    Reporter of the Form 4 filing

  • U S GLOBAL INVESTORS INC

    Issuer of the shares (ticker GROW)

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GROWMed

U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Quarter of Fiscal 2027

U S GLOBAL INVESTORS INC (GROW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Holly Schoenfeldt Director of Marketing and Public Relations 210.308.1268 hschoenfeldt@usfunds.com For Immediate Release U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Quarter of Fiscal 2027 *****************

$GROWMed

U.S. Global Investors Reports $3.1 Million in Net Income for Fiscal Year 2026

U S GLOBAL INVESTORS INC (GROW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Holly Schoenfeldt Director of Marketing and Public Relations 210.308.1268 hschoenfeldt@usfunds.com For Immediate Release U.S. Global Investors Reports $3.1 Million in Net Income for Fiscal Year 2026 ***********************************************************

$GROWLow

U.S. Global Investors Announces Restatement of EPS for Q3 2026; Reported Financial Strength Remains Unchanged

U S GLOBAL INVESTORS INC (GROW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_973695.htm EXHIBIT 99.1 ex_973695.htm Exhibit 99.1 Contact: Holly Schoenfeldt Director of Marketing and Public Relations 210.308.1268 hschoenfeldt@usfunds.com For Immediate Release U.S. Global Investors Announces Restatement of EPS for Q3 2026; Reported Financial Str

$GROWMedAI 8/10

U.S. Global Investors Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged

U.S. Global Investors (NASDAQ: GROW) said it will restate EPS for the three- and nine-month periods ended March 31, 2026, due to a miscalculation of basic and diluted weighted-average shares that omitted a component in a supporting spreadsheet. The company said net income, revenues, operating income, cash, and other line items are unchanged. For the quarter, EPS was overstated by $0.02; corrected basic/diluted EPS is $0.21. For nine months, overstated by $0.01; corrected EPS is reflected in an a